Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
QIN | Any update on the QIN class action? | 22/12/23 | 13 | 12K | |||
|
|||||||
QIN | Quintis Class Action | 21/12/23 | 5 | 2.8K | |||
|
|||||||
QIN | Dave Fenlon (Failure) | 13/08/22 | 2 | 3.2K | |||
|
|||||||
QIN | were there !! | 17/06/22 | 31 | 21K | |||
|
|||||||
QIN | Quintis Class Action news | 23/07/20 | 73 | 72K | |||
|
|||||||
QIN | RESPONSE TO GLAUCUS | 03/03/20 | 54 | 79K | |||
|
|||||||
QIN | News: QIN Kordamentha Says Quintis Creditors Trust Established | 05/11/19 | 1 | 3.3K | |||
|
|||||||
QIN | Ann: Suspension from Official Quotation - Annual Listing Fee | 11/09/19 | 9 | 7.8K | |||
|
See All Discussions